JELMYTO® (Mitomycin)

April 20, 2020April 20, 2020 RR FDA Approvals

The FDA on April 15, 2020 approved JELMYTO® for adult patients with low-grade upper tract urothelial cancer. JELMYTO® is a product of UroGen Pharma.